A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED)
Status:
Terminated
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This study will determine the best doses of docetaxel and lonafarnib when the two anti-cancer
agents are used in combination. Patients with tumors for which treatment with docetaxel would
be appropriate are eligible. A second part of the study will further examine the
effectiveness of the combination treatment in men with prostate cancer.